UBS Maintains a 'Neutral' on Church & Dwight Co. (CHD); Avid Acquisition

UBS maintains a 'Neutral' on Church & Dwight Co. Inc. (NYSE: CHD) price target of $53.00.

Analyst, Nik Modi, maintains his rating and price target on CHD, despite the company's recent acquisition announcement.

Last night (after the close), CHD agreed to acquire Avid Health, Inc. (Avid) for $650 million in cash.

Avid’s net sales for the trailing twelve months through June 30, 2012 were approximately $230 million. Avid’s major brands are VITAFUSION, the #1 brand in adult gummy form vitamins and L’IL CRITTERS, the #1 brand in children’s gummy form vitamins.

CHD reaffirmed FY12 EPS estimate between $2.41-2.43 (ex-$0.02 dilutive effect for AVID) vs. consensus of $2.42. CHD sees FY13 EPS between $2.73-2.78 vs. consensus $2.66 (which doesn't include AVID)

For an analyst ratings summary and ratings history on Church & Dwight Co. Inc. click here. For more ratings news on Church & Dwight Co. Inc. click here.

Shares of Church & Dwight Co. Inc. closed at $53.04 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
• UBS Reiterates Buy Rating on Hilton Worldwide (HLT)
• McGraw Hill (MH) PT Raised to $15 at UBS